EXAI BIO, INC.
RNA-based blood test for early cancer detection using AI analysis
- Sector
- Biotech
- Headquarters
- PALO ALTO, CA
- Founded
- 2021
- Latest Form D
- $70.6M, Oct 2022
- Total capital
- $71.9M
- Federal grants
- $1.3M
- 1 award · 2024
- Rank in peer group#1 of 32
- Private capital raised
- $70.6M
- 1 Form D · last Oct 2022
- 48 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 13 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Orphan Non-coding RNA-based Test for Detecting Minimal Residual Disease in Resectable Non-small Cell Lung Cancer$1.3M
- Private capital raisedForm D · SEC · 1st filing$70.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 32 peers
Line = medianBiotech · Instrument
- Federal grants#1 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alexander A. ParkerDirectorNamed in SEC Form D filings
- Hani A. GoodarziDirectorNamed in SEC Form D filings
- Michael A. PelliniDirectorNamed in SEC Form D filings
- Patrick A. ArensdorfExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 13- PendingSystems And Methods For Early-stage Cancer Detection And SubtypingUSPTOApplication 18636128
- PendingSystems And Methods For Detection Of Non-coding RnasUSPTOApplication PCTUS2025023242
- PendingSystems And Methods For Predicting Biomarker ExpressionUSPTOApplication 63692006
Show all 13 patent records
- Systems And Methods For Early-stage Cancer Detection And SubtypingOct 17, 2024 · Application 18636128Pending
- Systems And Methods For Detection Of Non-coding RnasApplication PCTUS2025023242Pending
- Systems And Methods For Predicting Biomarker ExpressionApplication 63692006Pending
- Systems And Methods For Detection Of Non-coding RnasApplication PCTUS2024036980Pending
- Systems And Methods For Analysis Of Small Rna K-mersApplication PCTUS2024035636Pending
- Systems And Methods For Early-stage Cancer Detection And SubtypingApplication PCTUS2024024682Pending
- Systems And Methods For Detection Of Non-coding RnasApplication 63574826Pending
- Systems And Methods For Detection Of Non-coding RnasApplication 63606474Pending
- Systems And Methods For Detection Of Non-coding RnasApplication 63605973Pending
- Systems And Methods For Detection Of Non-coding RnasApplication 63512579Pending
- Systems And Methods For Analysis Of Small Rna K-mersApplication 63510570Pending
- Systems And Methods For Predicting Biomaker ExpressionApplication PCTUS2025045229Pending
- Systems And Methods For Early-stage Cancer Detection And SubtypingApplication 63496344Pending
Related companies, and why
- CYTEGEN CORPSimilar federal contract value in Biotech · null in contracts
- BYOMASS, INC.Similar federal contract value in Biotech · null in contracts
- G1 THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- SPARIAN BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- INTRA THERAPEUTICS, LLCSimilar federal contract value in Biotech · null in contracts
- EXOTECT, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .